CANVAC JUNIOR, Lyofilizát a rozpouštědlo pro injekční suspenzi
CANVAC JUNIOR, Lyofilizát a rozpouštědlo pro injekční suspenzi
Authorised
- Canine distemper virus, Live
- Canine parvovirus, Live
Product identification
Medicine name:
CANVAC JUNIOR, Lyofilizát a rozpouštědlo pro injekční suspenzi
Active substance:
- Canine distemper virus, Live
- Canine parvovirus, Live
Target species:
-
Dog (puppy)
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, Live4.50log 10 50% embryo infective dose1.00Dose
-
Canine parvovirus, Live2048.00haemagglutinating units1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog (puppy)
- Dog
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dyntec spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Dyntec spol. s r.o.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
- 97/1157/97-C
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?: